These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15231431)

  • 21. New sustained release of zidovudine matrix tablets - cytotoxicity toward Caco-2 cells.
    Santos JV; Pina ME; Marques MP; de Carvalho LA
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1154-66. PubMed ID: 22439754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generalized regression neural networks in prediction of drug stability.
    Ibrić S; Jovanović M; Djurić Z; Parojcić J; Solomun L; Lucić B
    J Pharm Pharmacol; 2007 May; 59(5):745-50. PubMed ID: 17524242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies in preparation and evaluation of pH-independent sustained-release matrix tablets of verapamil HCl using directly compressible Eudragits.
    Gohel MC; Patel TP; Bariya SH
    Pharm Dev Technol; 2003; 8(4):323-33. PubMed ID: 14601957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Eudragit RS-PO and Ethocel 100 matrices for the controlled release of lobenzarit disodium.
    Boza A; Caraballo I; Alvarez-Fuentes J; Rabasco AM
    Drug Dev Ind Pharm; 1999 Feb; 25(2):229-33. PubMed ID: 10065357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
    Bendas ER; Christensen JM; Ayres JW
    Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of formulation on the dissolution profile of diclofenac sodium tablets.
    De Castro WV; Pires MA; Oliveira MA; Vianna-Soares CD; Nunan EA; Pianetti GA; Moreira-Campos LM; De Castro WV; Mertens-Talcott SU; Derendorf H
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1103-9. PubMed ID: 17012123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, development, and optimization of polymeric based-colonic drug delivery system of naproxen.
    Sharma P; Chawla A; Pawar P
    ScientificWorldJournal; 2013; 2013():654829. PubMed ID: 24198725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of Eudragit type on the dissolution rate of acetylsalicylic acid from matrix tablets.
    Jovanović M; Jovicić G; Djurić Z; Agbaba D; Karljiković-Rajić K; Nikolić L; Radovanović J
    Acta Pharm Hung; 1997 Nov; 67(6):229-34. PubMed ID: 9423294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of matrix tablets controlled drug release using Elman dynamic neural networks and decision trees.
    Petrović J; Ibrić S; Betz G; Đurić Z
    Int J Pharm; 2012 May; 428(1-2):57-67. PubMed ID: 22402474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tableting of Eudragit RS and propranolol hydrochloride solid dispersion: effect of particle size, compaction force, and plasticizer addition on drug release.
    Sadeghi F; Afrasiabi Garekani H; Goli F
    Drug Dev Ind Pharm; 2004 Aug; 30(7):759-66. PubMed ID: 15491053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
    Varum FJ; Hatton GB; Freire AC; Basit AW
    Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of channeling agents on the release pattern of theophylline from kollidon SR based matrix tablets.
    Ibn Razzak MS; Khan F; Hossain M; Khan MZ; Azad MA; Reza MS
    Pak J Pharm Sci; 2009 Jul; 22(3):303-7. PubMed ID: 19553179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.
    Kotagale N; Maniyar M; Somvanshi S; Umekar M; Patel CJ
    Pharm Dev Technol; 2010; 15(4):431-7. PubMed ID: 20236031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eudragit matrices for sustained release of ketorolac tromethamine: formulation and kinetics of release.
    Ruckmani K; Muneera MS; Vijaya R
    Boll Chim Farm; 2000; 139(5):205-8. PubMed ID: 11213438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosage form design and in vitro/in vivo evaluation of cevimeline extended-release tablet formulations.
    Tajiri S; Kanamaru T; Kamada M; Konno T; Nakagami H
    Int J Pharm; 2010 Jan; 383(1-2):99-105. PubMed ID: 19747964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix.
    Perez MA; Ghaly ES; Marti A
    P R Health Sci J; 1993 Dec; 12(4):263-7. PubMed ID: 8140204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
    Patel MM; Amin AF
    Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled-release cellulose esters matrices for water-soluble diclofenac sodium: compression and dissolution studies.
    Obeidat WM; Alzoubi NM
    Pharmazie; 2014 Feb; 69(2):96-103. PubMed ID: 24640597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: formulation, optimization and in vitro evaluation.
    Chawla A; Sharma P; Pawar P
    Acta Pharm; 2012 Dec; 62(4):529-45. PubMed ID: 23333888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.